⌘K

Home/Filings/4/0001127602-23-002135

4//SEC Filing

SCHEIBLER LUKAS 4

Accession 0001127602-23-002135

CIK 0001492422other

View on SEC.gov Company Profile

Filed

Jan 23, 7:00 PM ET

Accepted

Jan 24, 5:22 PM ET

Size

4.4 KB

Accession

0001127602-23-002135

Insider Transaction Report

Form 4

Period: 2023-01-20

Apellis Pharmaceuticals, Inc.APLS

SCHEIBLER LUKAS

See Remarks

Transactions

Tax Payment
Common Stock
2023-01-20$52.05/sh−2,015$104,881→ 61,692 total

Footnotes (1)

[F1]This represents shares withheld for tax on a restricted stock unit release.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

Apellis Pharmaceuticals, Inc.

CIK 0001492422

Entity typeother

Related Parties

1

filerCIK 0001651281

Filing Metadata

Form type: 4
Filed: Jan 23, 7:00 PM ET
Accepted: Jan 24, 5:22 PM ET
Size: 4.4 KB

View on SEC.gov